ciprofloxacin has been researched along with acriflavine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gutmann, L; Janoir, C; Kitzis, MD; Moreau, NJ; Zeller, V | 1 |
Böddinghaus, B; Böttger, EC; Branzoni, M; Cantoni, R; De Rossi, E; Lopez, G; Riccardi, G; Rodriquez, R; Sander, P; Takiff, H | 1 |
2 other study(ies) available for ciprofloxacin and acriflavine
Article | Year |
---|---|
Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.
Topics: 4-Quinolones; Acriflavine; Adenosine Triphosphate; Anti-Infective Agents; Anti-Infective Agents, Local; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cetrimonium; Cetrimonium Compounds; Ciprofloxacin; Drug Resistance, Microbial; Ethidium; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pefloxacin; Phenotype; Quinolones; Streptococcus pneumoniae; Transformation, Bacterial | 1997 |
Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance.
Topics: Acriflavine; Anti-Bacterial Agents; Antiporters; Bacterial Proteins; Ciprofloxacin; Doxorubicin; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethidium; Microbial Sensitivity Tests; Mutation; Mycobacterium smegmatis; Rhodamines | 2000 |